Home » Topics » Regulatory » Patents

Patents
RSS

Imidazole cytokine-suppressive antiinflammatory compounds from SB

Feb. 16, 1999

U.S. university researchers claim anti-HIV 2',5'-phosphorothioate/phosphodiester oligoadenylates

Feb. 15, 1999

U. of Arizona prepares novel cyanoaziridine-based antitumor agents

Feb. 15, 1999

Na+/H+ antiport inhibitors in development at Synthelabo

Feb. 15, 1999

SmithKline Beecham claims new series of inhibitors of cytokine production

Feb. 15, 1999

Novel NOS inhibitors prepared at Astra, claimed for use in inflammatory disorders

Feb. 15, 1999

New compounds from Novo Nordisk for pain, inflammation, diabetes

Feb. 12, 1999

New antiinflammatory/immunomodulatory compounds from Signal act at a transcriptional level

Feb. 12, 1999

Neurogen and Pfizer collaborate on development of NPY receptor ligands

Feb. 12, 1999

Astra describes N-type neuronal calcium channel blockers and their use

Feb. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...